Used in biomedical research to quantify levels of glycogen phosphorylase isozyme II in human tissue or serum samples. Helps in studying liver injury, particularly in cases of drug-induced hepatotoxicity or ischemic liver damage. The kit enables researchers to assess the release of GP-II as a biomarker for early detection of hepatocyte damage, offering higher specificity compared to traditional liver enzymes like ALT or AST. Commonly applied in preclinical studies, clinical diagnostics research, and pharmaceutical development to monitor liver health and evaluate the safety of new drug candidates.